AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

VERAPAMIL

10 registrations across 5 African markets— 6 active

Markets with VERAPAMIL

Recent registrations

Brand / ProductMarketHolderStatusExpires
ANGIGO 40MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireAUROCHEM PHARMACEUTICALS (INDIA) PVT.expiredMay 2018
ANGIGO 80MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireAUROCHEM PHARMACEUTICALS (INDIA) PVT.expiredMay 2018
ANGIGO 120MG COMPRIME BOITE DE 30🇨🇮Côte d'IvoireAUROCHEM PHARMACEUTICALS (INDIA) PVT.expiredJan 2018
ISOPTINE LP
Comprimé secable l.p / 240 mg
🇹🇳TunisiaMYLAN MEDICAL SASexpiredJul 2017
ISOPTIN 120 mg🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
VASOMIL INJECTION🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
ISOPTIN 80 mg🇿🇦South AfricaAbbott Laboratories S.A. (Pty) LtdactiveJan 1900
FIBROCARD LP
GELULE LP
🇲🇦Moroccoactive
FIBROCARD LP
GELULE LP
🇲🇦Moroccoactive
Caveril
Tablets
🇹🇿TanzaniaRemedica LTDactive

VERAPAMIL in Africa — Regulatory Overview

VERAPAMIL is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, South Africa, Morocco, Tunisia and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 6 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.